Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
8
×
detroit blog main
detroit top stories
indiana blog main
8
×
indiana top stories
life sciences
national
national blog main
national top stories
8
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
8
×
boston top stories
startups
europe blog main
europe top stories
fda
novartis
abbvie
alzheimer's disease
amgen
clinical trials
deals
eli lilly
ipo
What
bio
roundup
8
×
new
acquisitions
buy
ceo
covid
daniel
debut
drug
gilead
ipo
life
medicines
moves
o’day
science
sciences
week
abbvie’s
activity
advantages
alliance
announced
approvals
bails
bar
barbecuing
biggest
biogen
black
brand
bridgebio
brings
bristol
build
calls
camping
capital
car
Language
unset
8
×
Current search:
roundup
×
cancer
×
unset
×
" national top stories "
×
" indiana blog main "
×
" wisconsin top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More